|
|
|
|
|
by jjcon
1906 days ago
|
|
Efficacious vaccine candidates are high in supply (moderna, Pfizer, j&j, AstraZeneca etc etc) - massive manufacturing capacity, testing and clinical trial ability however is not. If Pfizer hadn’t partnered with biontech they wouldn’t have idle manufacturing, they would have partnered with another lab to create something else. Apple is a customer of TSMC - they pay for fab time to create a specific component they need for their devices. Pfizer and biontech however are splitting the development costs and sharing the profits. That is a very different relationship. |
|
This America first thing is becoming really annoying for the rest of the world. Germany and the EU funded much of the vaccine's development. It's the EU who is supplying the world with vaccines. The US only stand out by blocking exports.